Streptococcal toxic shock syndrome presenting with spontaneous hypoglycemia in a chronic hemodialysis patient: Pathophysiological mechanisms

Internal Medicine

Volumn 42, Issue 5, 2003, Pages 421-423

  Igaki, Naoya ^b   Matsuda, Tomokazu ^b   Hirota, Yushi ^a   Kawaguchi, Takayuki ^b   Tamada, Fumihiko ^b   Goto, Takeo ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Takasago Municipal Hospital   (Japan)

Author keywords

Hepatic glucose output; Peripheral glucose utilization; Renal gluconeogenesis; Sepsi

Indexed keywords

CILASTATIN PLUS IMIPENEM; DOPAMINE; ENDOTOXIN; GLUCOSE; IMMUNOGLOBULIN; INSULIN; METHYLPREDNISOLONE; STREPTOCOCCUS ENDOTOXIN; SULTAMICILLIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; AUTOPSY; CASE REPORT; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FATALITY; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HEMODIALYSIS PATIENT; HUMAN; HYPOGLYCEMIA; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; KIDNEY FAILURE; LABORATORY TEST; PHYSICAL EXAMINATION; SEPSIS; STREPTOCOCCUS INFECTION; TOXIC SHOCK SYNDROME;

EID: 0037837086     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.421     Document Type: Article

References (14)

1. Haviv YS, Sharkia M, Safadi R. Hypoglycemia in patients with renal failure. Ren Fail 22: 219-223, 2000.
2. Adrogué HJ. Glucose homeostasis and the kidney. Kidney Int 42: 1266-1282, 1992.
3. Alvestrand A. Carbohydrate and insulin metabolism in renal failure. Kidney Int Suppl 62: S48-S52, 1997.
4. Mak RH. Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int 54: 603-607, 1998.
5. Foss MC, Gouveia LM, Moyses Neto M, Paccola GM, Piccinato CE. Effect of hemodialysis on peripheral glucose metabolism of patients with chronic renal failure. Nephron 73: 48-53, 1996.
6. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 269: 390-391, 1993.
7. Maitra SR, Wojnar MM, Lang CH. Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis. Shock 13: 379-385, 2000.
8. Wolfe RR. Sepsis as a modulator of adaptation to low and high carbohydrate and low and high fat intakes. Eur J Clin Nutr Suppl 1: S136-S142, 1999.
9. Gerich JE, Meyer C, Woerle HJ, Stumvoll M. Renal gluconeogenesisits importance in human glucose homeostasis. Diabetes Care 24: 382-391, 2001.
10. Meyer C, Dostou JM, Gerich JE. Role of the human kidney in glucose conterregulation. Diabetes 48: 943-948, 1999.
11. Stumvoll M. Glucose production by the human kidney-its importance has been underestimated. Nephrol Dial Transplant 13: 2996-2999, 1998.
12. Ekberg K, Landau BR, Wajngot A, et al. Contibutions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes 48: 292-298, 1999.
13. Goto M, Zeller WP, Lichtenberg RC. Decreased gluconeogenesis and increased glucose disposal without hyperinsulinemia in 10-day-old rats with endotoxic shock. Metabolism 43: 1248-1254, 1994.
14. Deutschman C, Andrejko KM, Haber BA, et al. Sepsis-induced depression of rat glucose-6-phosphatase gene expression and activity. Am J Physiol 273: R1709-R1718, 1997.